Jurrien M. ten Berg, MD, PhD

Original Contribution

Net Clinical Benefit of Prehospital Glycoprotein IIb/IIIa Inhibitors in Patients with ST-Elevation Myocardial Infarction and High Risk of Bleeding: Effect of Tirofiban in Patients at High Risk of Bleeding Using CRUSADE Bleeding Score

02/29/2012

Christian W. Hamm , MD, PhD, FESC;

Jurrien M. ten Berg , MD, PhD;

Arnoud W.J. van't Hof , MD, PhD;

Renicus S. Hermanides , MD;

A.T. Marcel Gosselink , MD, PhD;

Gert van Houwelingen , MD;

Jan-Henk E. Dambrink , MD, PhD;

Pieter R. Stella , MD, PhD;

Jan Paul Ottervanger , MD, PhD;

Abstract: Aims. The aim of this subanalysis was to assess the net clinical effect of prehospital administration of tirofiban in ST-elevation myocardial infarction (STEMI) patients with high risk of bleeding. Methods. This is a retrospective...

Abstract: Aims. The aim of this...

02/29/2012

Journal of Invasive Cardiology

VA-ECMO With IABP is Associated With Better Outcome Than VA-ECMO Alone in the Treatment of Cardiogenic Shock in ST-Elevation Myocardial Infarction

05/01/2021

Tessel N. Vossenberg , MD;

Gabe B. Bleeker , MD, PhD;

Vivian L. Winia , MD;

Krischan D. Sjauw , MD, PhD;

Jurrien M. ten Berg , MD, PhD;

Floris S. van den Brink , MD, PhD;

Carlo Zivelonghi , MD;

This study assesses whether combining venoarterial extracorporeal membrane oxygenation (VA-ECMO) with intra-aortic balloon pump (IABP) improves outcomes in ST-segment elevation myocardial infarction (STEMI) over VA-ECMO alone.

This study assesses whether...

05/01/2021

Journal of Invasive Cardiology